Related Experiment Video
Updated: Jul 8, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Dilated conjunctival vessels in a patient undergoing epoprostenol therapy
Abstract:
A 44-year-old man with primary pulmonary hypertension was referred for a possible carotid-cavernous fistula. Since initiation of epoprostenol therapy 3 months prior to presentation, he noticed progressive redness in both eyes and a macular rash, primarily involving the face and abdomen. Examination revealed engorged superficial conjunctival vessels in both eyes. Magnetic resonance imaging and angiography of the brain and orbits revealed no evidence of an arteriovenous fistula. Epoprostenol, a vasodilator, was associated with dilated conjunctival vessels in this patient.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems